PLACENTAL GROWTH FACTOR FOR THE TREATMENT OF FETAL ALCOHOL SYNDROME DISORDERS (FASD)

PLACENTAL GROWTH FACTOR FOR THE TREATMENT OF FETAL ALCOHOL SYNDROME DISORDERS (FASD)

The invention relates to a placental growth factor (PlGF) to be used as a drug in the prevention and/or treatment of fetal alcohol syndrome disorders (FASD) selected from the group comprising fetal alcohol syndrome (FAS), cerebrovascular disease, and growth retardation in a subject exposed to alcoho...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: UNIVERSITE DE ROUEN NORMANDIE, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), CENTRE HOSPITALIER UNIVERSITAIRE DE ROUEN
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator UNIVERSITE DE ROUEN NORMANDIE
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
CENTRE HOSPITALIER UNIVERSITAIRE DE ROUEN
description The invention relates to a placental growth factor (PlGF) to be used as a drug in the prevention and/or treatment of fetal alcohol syndrome disorders (FASD) selected from the group comprising fetal alcohol syndrome (FAS), cerebrovascular disease, and growth retardation in a subject exposed to alcohol in utero. The invention also relates to a pharmaceutical composition or a product comprising the PlGF for the same therapeutic uses.
format Patent
fullrecord <record><control><sourceid>uspatents_EFI</sourceid><recordid>TN_cdi_uspatents_applications_16465465</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20190351018</sourcerecordid><originalsourceid>FETCH-uspatents_applications_164654653</originalsourceid><addsrcrecordid>eNrjZAgJ8HF0dvULcfRRcA_yDw_xUHBzdA7xD1JwA-IQD1eFkCBXxxBfoAoFfzcFN1eQQkcfZ38Pfx-F4Eg_lyB_X1cFF89g_yAX16BgBQ03x2AXTR4G1rTEnOJUXijNzaAG1OnsoVtaXJBYkppXUhyfWFCQk5mcWJKZn1ccb2hmYmYKRMZEKwQAeew1yw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PLACENTAL GROWTH FACTOR FOR THE TREATMENT OF FETAL ALCOHOL SYNDROME DISORDERS (FASD)</title><source>USPTO Published Applications</source><creator>UNIVERSITE DE ROUEN NORMANDIE ; INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) ; CENTRE HOSPITALIER UNIVERSITAIRE DE ROUEN</creator><creatorcontrib>UNIVERSITE DE ROUEN NORMANDIE ; INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) ; CENTRE HOSPITALIER UNIVERSITAIRE DE ROUEN</creatorcontrib><description>The invention relates to a placental growth factor (PlGF) to be used as a drug in the prevention and/or treatment of fetal alcohol syndrome disorders (FASD) selected from the group comprising fetal alcohol syndrome (FAS), cerebrovascular disease, and growth retardation in a subject exposed to alcohol in utero. The invention also relates to a pharmaceutical composition or a product comprising the PlGF for the same therapeutic uses.</description><language>eng</language><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/20190351018$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,776,869,881,64036</link.rule.ids><linktorsrc>$$Uhttps://patentcenter.uspto.gov/applications/16465465$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>UNIVERSITE DE ROUEN NORMANDIE</creatorcontrib><creatorcontrib>INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)</creatorcontrib><creatorcontrib>CENTRE HOSPITALIER UNIVERSITAIRE DE ROUEN</creatorcontrib><title>PLACENTAL GROWTH FACTOR FOR THE TREATMENT OF FETAL ALCOHOL SYNDROME DISORDERS (FASD)</title><description>The invention relates to a placental growth factor (PlGF) to be used as a drug in the prevention and/or treatment of fetal alcohol syndrome disorders (FASD) selected from the group comprising fetal alcohol syndrome (FAS), cerebrovascular disease, and growth retardation in a subject exposed to alcohol in utero. The invention also relates to a pharmaceutical composition or a product comprising the PlGF for the same therapeutic uses.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EFI</sourceid><recordid>eNrjZAgJ8HF0dvULcfRRcA_yDw_xUHBzdA7xD1JwA-IQD1eFkCBXxxBfoAoFfzcFN1eQQkcfZ38Pfx-F4Eg_lyB_X1cFF89g_yAX16BgBQ03x2AXTR4G1rTEnOJUXijNzaAG1OnsoVtaXJBYkppXUhyfWFCQk5mcWJKZn1ccb2hmYmYKRMZEKwQAeew1yw</recordid><startdate>20171201</startdate><enddate>20171201</enddate><creator>UNIVERSITE DE ROUEN NORMANDIE</creator><creator>INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)</creator><creator>CENTRE HOSPITALIER UNIVERSITAIRE DE ROUEN</creator><scope>EFI</scope></search><sort><creationdate>20171201</creationdate><title>PLACENTAL GROWTH FACTOR FOR THE TREATMENT OF FETAL ALCOHOL SYNDROME DISORDERS (FASD)</title></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_applications_164654653</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2017</creationdate><toplevel>online_resources</toplevel><creatorcontrib>UNIVERSITE DE ROUEN NORMANDIE</creatorcontrib><creatorcontrib>INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)</creatorcontrib><creatorcontrib>CENTRE HOSPITALIER UNIVERSITAIRE DE ROUEN</creatorcontrib><collection>USPTO Published Applications</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><aucorp>UNIVERSITE DE ROUEN NORMANDIE</aucorp><aucorp>INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)</aucorp><aucorp>CENTRE HOSPITALIER UNIVERSITAIRE DE ROUEN</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PLACENTAL GROWTH FACTOR FOR THE TREATMENT OF FETAL ALCOHOL SYNDROME DISORDERS (FASD)</title><date>2017-12-01</date><risdate>2017</risdate><abstract>The invention relates to a placental growth factor (PlGF) to be used as a drug in the prevention and/or treatment of fetal alcohol syndrome disorders (FASD) selected from the group comprising fetal alcohol syndrome (FAS), cerebrovascular disease, and growth retardation in a subject exposed to alcohol in utero. The invention also relates to a pharmaceutical composition or a product comprising the PlGF for the same therapeutic uses.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_uspatents_applications_16465465
source USPTO Published Applications
title PLACENTAL GROWTH FACTOR FOR THE TREATMENT OF FETAL ALCOHOL SYNDROME DISORDERS (FASD)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T08%3A28%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFI&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.aucorp=UNIVERSITE%20DE%20ROUEN%20NORMANDIE&rft.date=2017-12-01&rft_id=info:doi/&rft_dat=%3Cuspatents_EFI%3E20190351018%3C/uspatents_EFI%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true